Cytos Biotechnology AG Says Pfizer Inc. Takes Commercial Licenses For Some Vaccines

ZURICH -(Dow Jones)- Swiss biotechnology company Cytos Biotechnology Ltd said Monday Pfizer Inc. has taken commercial licenses for specified vaccines based on Cytos' immunodrug technology, based on a research, option and license agreement signed by the two companies in August. The event triggers payments to Cytos, but spokeswoman Claudine Blaser didn't reveal the amount to be paid to Cytos now.

Back to news